Introduction {#s1}
============

The study of the consequences of the loss of gene function is a central technique in biology. In principle, loss of gene function can be achieved through gene, mRNA or protein inactivation. While there are many techniques available to inactivate genes and mRNA globally, spatially and temporally ([@bib20]), methods to reduce protein function in the same manner are more limited. One strategy to inactivate a specific protein is to fuse it to a degron, a protein domain that targets its fusion partner for degradation. Degrons are recognized by adapter proteins. These adapter proteins target the degron together with its fusion partner to the E3 ubiquitin ligase complex for degradation by the proteasome. By manipulating degrons with temperature, light, small molecules or another protein, protein-degron fusions can also be degraded in a controlled manner ([@bib36]). While different versions of these approaches have been adapted to zebrafish, it is mostly unclear whether they degrade the protein-degron efficiently enough to cause a phenotype ([@bib3]; [@bib41]; [@bib10]; [@bib37]).

GFP-based fluorescent proteins (FPs) are convenient degrons because they are often used to tag proteins and their degradation can be easily monitored by light microscopy. deGradFP, a system developed in flies, depletes FP-tagged proteins ([@bib6]; [@bib34]). It relies on the expression of an anti-GFP nanobody/F-box fusion protein. This fusion protein recruits FP-tagged proteins to the SKP1- CUL1-F-box (SCF) E3 ubiquitin ligase complex, leading to its ubiquitylation and proteasome-mediated degradation in 2-3 hr. Slight variations of this system have been used to deplete FP-tagged proteins in different tissues in nematodes ([@bib47]), flies ([@bib4]) and in zebrafish nuclei ([@bib41]).

Here, we surveyed different degron systems in zebrafish and identified an anti-GFP nanobody/F-box fusion protein, which we named zGrad, that efficiently degrades FP-tagged proteins in zebrafish. We used this system to show that zGrad depletes FP-tagged proteins within 30 to 150 min depending on the subcellular localization and the nature of the tagged protein. We found that zGrad-mediated protein degradation recapitulates genetic loss-of-function phenotypes and can uncover severe maternal and maternal-zygotic phenotypes. When we induced zGrad from a heat-shock-inducible promoter, we found temporal degradation of FP-tagged proteins with acute and reversible loss-of-protein function phenotypes. Lastly, we expressed zGrad from a tissue-specific promoter and found degradation of FP-tagged proteins exposing a phenotype similar to but less severe than the genetic loss-of-function phenotype. These observations indicate that zGrad is a versatile tool to rapidly and reversibly deplete FP-tagged proteins with temporal or spatial control in zebrafish.

Results {#s2}
=======

zGrad efficiently degrades GFP-tagged proteins in zebrafish {#s2-1}
-----------------------------------------------------------

To establish a method to reduce the activity of proteins in zebrafish, we tested several degron-based protein degradation systems. First, we tested the auxin-inducible degron (AID) system ([@bib35]; [@bib38]; [@bib18]; [@bib14]). This system uses the plant F box transport inhibitor response 1 (TIR1) protein to recruit proteins tagged with the small AID degron to the SCF E3 ubiquitin ligase complex in an auxin-dependent manner ([Figure 1A](#fig1){ref-type="fig"}). We co-injected one-cell stage embryos with *sfGFP-mAID* mRNA and varying amounts of *OsTIR1-mCherry* mRNA and treated them for 3 hr with or without the auxin analog indole-3-acetic acid (IAA). We found that expression of OsTIR1-mCherry induced degradation of sfGFP-mAID in a dose-dependent manner irrespective of IAA ([Figure 1D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). We also found that 50 pg/embryo or higher concentrations of *OsTIR1-mCherry* mRNA led to deformed and dying embryos ([Figure 1---figure supplement 1B,C](#fig1s1){ref-type="fig"}). Thus, low levels of OsTIR1 induce degradation of AID-tagged proteins, higher levels of OsTIR1 are toxic and OsTIR degrades AID-tagged proteins in the absence of auxin, suggesting that, in its current form, the AID system is not suitable to degrade proteins in zebrafish.

![zGrad degrades GFP-tagged proteins in zebrafish.\
(**A**) Overview of degron-based protein degradation systems. POI: protein of interest. (**B**) Comparison of deGradFP and zGrad fusion proteins. (**C**) Schematic of zGrad-mediated target protein degradation. (**D**) Representative images of embryos injected with *sfGFP-mAID* mRNA (210 pg) only (top) or with *sfGFP-mAID* mRNA (210 pg) and *OsTIR1-mCherry* mRNA (42 pg) (bottom) before (left, 8 hpf) and after IAA (500 µM) induction for 3 hr (middle and right, 11 hpf). Red channel is shown as a fire map (right). Scale bar: 1 mm. (**E**) Representative images of embryos injected with *sfGFP-ZF1* mRNA and *mScarlet-V5* mRNA only (left) or with *sfGFP-ZF1* mRNA and *mScarlet-V5* mRNA and *zif-1* mRNA (right) at 9 hpf. Scale bar: 200 µm. Note that mScarlet-V5 fluorescence served as an internal control. (**F**) Single-plane confocal images of cells in embryos injected with *sfGFP-ZF1* mRNA, *mScarlet-V5* mRNA and *abmut-spop* mRNA (left) or *ab-spop* mRNA (right) at 9 hpf. Scale bar: 20 µm. (**G**) Representative images of embryos injected with *sfGFP-ZF1* mRNA and *mScarlet-V5* mRNA (left) or with *sfGFP-ZF1* mRNA and *mScarlet-V5* mRNA and *deGradFP* mRNA (middle) or *zGrad* mRNA (right) at 9 hpf. Scale bar: 200 µm. (**H**) Quantification of control and Zif-1-mediated sfGFP-ZF1 degradation shown in E (blue), Abmut-SPOP control and Ab-SPOP-mediated sfGFP-ZF1 degradation shown in F (green), and deGradFP-mediated and zGrad-mediated sfGFP-ZF1 degradation shown in G (red). Mean, SD and n are indicated. \*\*p\<0.01. .](elife-43125-fig1){#fig1}

Second, we tested the ZIF-1/ZF1 tag degradation system. This system uses the *C. elegans* SOCS-box adaptor protein ZIF-1 which binds to the zinc-finger domain ZF1 to recruit ZF1-containing protein to the ECS (Elongin-C, Cul2, SOCS-box family) E3 ubiquitin ligase complex for proteasomal destruction ([Figure 1A](#fig1){ref-type="fig"}) ([@bib1]). We co-injected one-cell stage embryos with *sfGFP-ZF1* mRNA, *zif-1* mRNA and *mScarlet-V5* mRNA and assessed sfGFP-ZF1 degradation 9 hr later at the epiboly stage. The sequences of the ZF1 tag and ZIF-1 were codon optimized for zebrafish and mScarlet-V5 served as an internal standard. Using the ratio of sfGFP to mScarlet fluorescence intensity as a measure, we found that the ZIF-1/ZF1 tag degradation only reduced the levels of sfGFP-ZF1 by 17% ([Figure 1E,H](#fig1){ref-type="fig"}), indicating that the ZIF-1/ZF1 tag degradation system does not efficiently degrade ZF1-tagged proteins in zebrafish.

Third, we tested the Ab-SPOP/FP-tag degradation system. This system uses the CULLIN-binding domain from the human Speckle Type BTB/POZ Protein (SPOP) adaptor protein fused to the single domain anti-GFP nanobody vhhGFP4 ([Figure 1A](#fig1){ref-type="fig"}) ([@bib41]). The Ab-SPOP hybrid adaptor protein targets nuclear but not cytoplasmic FP-tagged proteins for degradation. We co-injected one-cell stage embryos with *sfGFP-ZF1* mRNA, *Ab-SPOP* mRNA or *Abmut-SPOP* mRNA and *mScarlet-V5* mRNA and assessed sfGFP-ZF1 degradation 9 hr later at the epiboly stage. Abmut-SPOP is a negative control and does not bind FPs because the GFP-binding domain in the nanobody is deleted ([@bib41]). We assessed the degree of GFP degradation as the ratio of sfGFP to mScarlet fluorescence intensity in the cytoplasm and the nucleus. Consistent with the initial description ([@bib41]), Ab-SPOP efficiently degraded nuclear sfGFP-ZF1 (70% reduction, [Figure 1F,H](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}) but not cytoplasmic sfGFP-ZF1 (13% reduction, [Figure 1F,H](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Abmut-SPOP did not cause any detectable sfGFP-ZF1 degradation ([Figure 1F](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). As reported previously ([@bib41]), this confirms that the Ab-SPOP/FP-tag degradation system degrades nuclear proteins efficiently but is not suitable for the degradation of non-nuclear proteins in zebrafish.

Fourth, we tested the degrade Green Fluorescent Protein (deGradFP) system. This system uses the F-box domain from the *Drosophila* Slimb adaptor protein fused to the anti-GFP nanobody vhhGFP4 to target FP-tagged proteins for degradation ([Figure 1A and B](#fig1){ref-type="fig"} and [@bib6]). We co-injected one-cell stage embryos with *sfGFP-ZF1* mRNA, *deGradFP* mRNA and *mScarlet-V5* mRNA and assessed sfGFP-ZF1 degradation 9 hr later at the epiboly stage. As above, mScarlet-V5 served as an internal standard and GFP degradation was assessed as the ratio of sfGFP to mScarlet fluorescence intensity. We found that deGradFP reduced sfGFP-ZF1 only slightly (19% reduction, [Figure 1G,H](#fig1){ref-type="fig"}). Since the fusion of the anti-GFP nanobody to the Cullin-binding domain from SPOP resulted in efficient albeit only nuclear degradation of GFP, we reasoned that the anti-GFP nanobody recognizes GFP-tagged proteins but that the Slimb F-box domain is not efficiently recruited to the E3 ligase complex in zebrafish. We therefore replaced the Slimb F-box domain in deGradFP with the homologuous F-box domain from zebrafish, reasoning that this should result in more efficient GFP degradation in zebrafish. Based on sequence homology, we identified the zebrafish *F-box and WD repeat domain containing 11b* (*fbxw11b)* gene as the *Drosophila slmb* orthologue. We then replaced the *Drosophila* F-box domain from Slimb in deGradFP with the zebrafish F-box domain from Fbxw11b ([Figure 1B,C](#fig1){ref-type="fig"}). We named this hybrid adaptor protein zGrad for zebrafish deGradFP. To test whether zGrad degrades GFP-tagged proteins, we co-injected one-cell stage embryos with *sfGFP-ZF1* mRNA, *zGrad* mRNA and *mScarlet-V5* mRNA and assessed sfGFP-ZF1 degradation 9 hr later at the epiboly stage using the ratio of sfGFP to mScarlet fluorescence intensity. In contrast to deGradFP, which depleted 19% of sfGFP-ZF1, zGrad depleted sfGFP-ZF1 in both the cytoplasm and the nucleus by 89% ([Figure 1G,H](#fig1){ref-type="fig"}). Importantly, we observed degradation of sfGFP-ZF1 by zGrad already at 2.5 hpf ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). Together, this indicates that zGrad efficiently targets tagged GFP in the cytoplasm for degradation and should be suitable for assessing protein function in zebrafish.

zGrad degrades nuclear, transmembrane and cytoplasmic FP-tagged proteins {#s2-2}
------------------------------------------------------------------------

Next, we asked whether zGrad degrades GFP-tagged proteins in different cellular compartments using a transgenic line that expresses zGrad from a heat-shock-inducible promoter in the embryo (*hsp70l:zGrad*).

First, we tested whether zGrad degrades the nuclear protein Histone 2A (H2A). We generated *hsp70l:zGrad* embryos that also expressed H2A-EGFP and H2A-mCherry from two identical 69 kb genomic fragments spanning the *cxcr4b* locus (*cxcr4b:H2A-GFP; cxcr4b:H2A-mCherry*). Among other tissues, the *cxcr4b* promoter drives expression in the somites and the posterior lateral line primordium (primordium) ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) ([@bib7]). Such embryos were heat shocked at 30 hpf for 1 hr and imaged over 9.5 hr. Compared to control embryos that did not carry the *hsp70l:zGrad* transgene, H2A-EGFP degradation was discernible in zGrad-expressing embryos within 2-3 hr post heat shock in all tissues that expressed nuclear EGFP from the *cxcr4b* promoter (skin, pronephros, somites, neural tube and primordium, [Figure 2A--E](#fig2){ref-type="fig"}, [Figure 2---Video 1](#fig2video1){ref-type="video"}). We quantified H2A-EGFP levels in heat-shocked control embryos and heat-shocked *hsp70l:zGrad* embryos using the fluorescence intensity of H2A-mCherry as a reference. Since H2A-mCherry was expressed from the same promoter as H2A-EGFP and since H2A-mCherry is not recognized by the anti-GFP nanobody and should not be subjected to zGrad-mediated protein degradation ([@bib6]), comparing the ratio of H2A-mCherry expression levels to H2A-EGFP should be a measure of H2A-EGFP in the absence of zGrad-mediated degradation. Further, we normalized the H2A-EGFP-to-H2A-mCherry fluorescence intensity ratios between zGrad-expressing and heat-shocked control embryos. In the somites, the levels of H2A-EGFP was decreased by 87% ([Figure 2C](#fig2){ref-type="fig"}), while in the primordium, the levels of H2A-EGFP was decreased by 22% ([Figure 2E](#fig2){ref-type="fig"}). The more efficient degradation of H2A-EGFP in the somites than in the primordium is probably due to the lower levels of H2A-EGFP and the lack of H2A-EGFP production in the somites at the time of zGrad induction ([Figure 2---figure supplements 1](#fig2s1){ref-type="fig"} and [2](#fig2s2){ref-type="fig"}) ([@bib7]).

![zGrad degrades nuclear, transmembrane and cytoplasmic proteins.\
(**A**) Schematic of strategy to assess zGrad-mediated H2A-EGFP degradation in the somites and the primordium. (**B**) Maximum-projected confocal images of nuclei in the somites in heat-shocked *cxcr4b:H2A-EGFP; cxcr4b:H2A-mCherry* embryos transgenic for *hsp70l:zGrad* (right) or not (left) at indicated time in min after the end of heat shock (29--30 hpf). Scale bar: 20 µm. (**C**) Left, quantification of H2A-EGFP-to-H2A-mCherry ratios in the somites of control (blue) and zGrad-expressing embryos (red) after the end of heat shock in min. Mean and SD are indicated. Right, H2A-EGFP-to-H2A-mCherry ratio of zGrad-expressing embryos normalized to control embryos (black dots) and fitted to a one-exponential decay model (red). (**D**) Maximum-projected confocal images of primordium nuclei in heat-shocked *cxcr4b:H2A-EGFP; cxcr4b:H2A-mCherry* embryos transgenic for *hsp70l:zGrad* (bottom) or not (top) at indicated time in min after the end of heat shock (29--30 hpf). Scale bar: 50 µm. (**E**) Left, quantification of H2A-EGFP-to-H2A-mCherry ratios in the primordia of control (blue) and zGrad-expressing embryos (red) after the end of heat shock in min. Mean and SD are indicated. Right, H2A-EGFP-to-H2A-mCherry ratio of zGrad-expressing embryos normalized to control embryos (black dots) and fit to a one-exponential decay model (red). (**F**) Schematic of strategy to assess zGrad-mediated Cdh1-sfGFP degradation in the skin (enveloping and epidermal basal layer). (**G**) Maximum-projected confocal images of the skin in heat-shocked *cdh1:cdh1-sfGFP; cdh1:cdh1-TagRFP* embryos transgenic for *hsp70l:zGrad* (right) or not (left) at indicated time in min after the end of heat shock (31 hpf). Scale bar: 10 µm. (**H**) Top, quantification of Cdh1-sfGFP-to-Cdh1-TagRFP ratios in the primordia of control (blue) and zGrad-expressing embryos (red) after the end of heat shock in min. Mean and SD are indicated. Bottom, Cdh1-sfGFP-to-Cdh1-TagRFP ratio of zGrad-expressing embryos normalized to control embryos (black dots) and fit to a one-exponential decay model (red). (**I**) Schematic of strategy to assess zGrad-mediated Ctnna-Citrine degradation in the skin. (**J**) Maximum-projected confocal images of skin cells in heat-shocked *ctnna:ctnna-Citrine/+* embryos transgenic for *hsp70l:zGrad* (right) or non-*hsp70l:zGrad* transgenic controls (left) at indicated time in min past the end of heat shock (31 hpf). Scale bar: 50 µm. (**K**) Left, quantification of Ctnna-Citrine levels in the skin of control (blue) and zGrad-expressing embryos (red) after the end of heat shock in min. Mean and SD are indicated. Right, Ctnna-Citrine levels in zGrad-expressing embryos normalized to Ctnna-Citrine levels in control embryos (black dots) and fit to a one-exponential decay model (red).](elife-43125-fig2){#fig2}

We further characterized the kinetics of zGrad-mediated degradation by determining the time interval between the start of the heat shock to induce zGrad expression and the first observable difference in EGFP/mCherry levels between zGrad-expressing embryos and control embryos. We called this time interval the time for onset of degradation. We also fitted the EGFP/mCherry ratio to a one-phase exponential decay model to extract the half-life of zGrad-mediated degradation. Although this is a simplification because the model does not account for EGFP production -- a variable that we cannot easily measure -- we expect that it gives a rough estimate for the time it takes to degrade a GFP-tagged protein once zGrad is expressed. The time for onset of degradation and half-life for H2A-EGFP in the somites was 200 min and 156 min, respectively ([Figure 2C](#fig2){ref-type="fig"}, [Table 1](#table1){ref-type="table"}). The time for onset of degradation and the half-life for H2A-EGFP degradation in the primordium was 140 min and 29 min, respectively ([Figure 2E](#fig2){ref-type="fig"}, [Table 1](#table1){ref-type="table"}).

10.7554/eLife.43125.013

###### *Cdh1* transgenic lines rescue *cdh1* mutants.

  Transgenic line       Total number of embryos   Transgenic embryos phenotypically wild type   Non-transgenic embryos phenotypically wild type   Embryos phenotypically *cdh1* mutant
  --------------------- ------------------------- --------------------------------------------- ------------------------------------------------- --------------------------------------
   *cdh1:cdh1-sfGFP*    306 (100 %)               149 (47 %)                                    96 (33 %)                                         61 (20 %)
   *cdh1:cdh1-TagRFP*   432 (100 %)               204 (47 %)                                    172 (40 %)                                        56 (13%)

10.7554/eLife.43125.014

###### Summary of degradation kinetics.

  -----------------------------------------------------------------------------------------------------------------------------------------
  FP-Tagged protein   Promoter expressing zGrad   Percent reduction   Degradation half-life in min   Time for onset of degradation in min
  ------------------- --------------------------- ------------------- ------------------------------ --------------------------------------
  sfGFP-ZF1           mRNA                        89%                 N/A                            N/A

  Cxcr4b-EGFP         *cxcr4b*                    86%                 N/A                            N/A

  H2A-EGFP\           *hsp70l*                    87%                 156                            200
  (in somites)                                                                                       

  H2A-EGFP\           *hsp70l*                    22%                 *29^**†**^*                    140
  (in primordium)                                                                                    

  Cdh1-sfGFP          *hsp70l*                    79%                 24                             75

  Ctnna-Citrine       *hsp70l*                    58%                 19                             65
  -----------------------------------------------------------------------------------------------------------------------------------------

^**†**^Note that the zGrad-mediated degradation of H2A-EGFP in the primordium is obscured by the continued production of H2A-EGFP.

Second, we tested whether zGrad degrades the transmembrane protein E-Cadherin (Cdh1). We generated two transgenes that express Cdh1-sfGFP and Cdh1-TagRFP from a 72 kb genomic fragment spanning the *cdh1* locus (*cdh1:cdh1-sfGFP; cdh1:cdh1-TagRFP*). These transgenes recapitulated the endogenous Cdh1 expression pattern and rescued the lethality of *cdh1* mutant embryos ([Table 2](#table2){ref-type="table"}), indicating that Cdh1-sfGFP and Cdh1-TagRFP are functional. Using these lines, we generated *hsp70l:zGrad; cdh1:cdh1-sfGFP; cdh1:cdh1-TagRFP* embryos and *cdh1:cdh1-sfGFP; cdh1:cdh1-TagRFP* control embryos. These embryos were heat shocked at 31 hpf for 30 min and imaged for 4.8 hr. In zGrad-expressing embryos, Cdh1-sfGFP degradation was uniformly detected within 15 min post heat shock in the skin of the embryo (enveloping layer and epidermal basal layer) ([Figure 2F--H](#fig2){ref-type="fig"}, [Figure 2---Video 2](#fig2video2){ref-type="video"}). As detailed above for the quantification of zGrad-mediated H2A-EGFP degradation, we used the fluorescence intensity of Cdh1-TagRFP as a reference to quantify the reduction of Cdh1-sfGFP. We divided the Cdh1-sfGFP fluorescence intensity by the Cdh1-TagRFP fluorescence intensity and normalized the ratio in the zGrad-expressing embryos to the ratio in the heat-shocked control embryos. This analysis showed that zGrad expression reduced the levels of Cdh1-sfGFP in the primordium by 79% with a degradation half-life of 24 min ([Figure 2H](#fig2){ref-type="fig"}). The time for onset of Cdh1-sfGFP degradation was 75 min ([Table 1](#table1){ref-type="table"}).

Third, we tested whether zGrad degrades the cytoplasmic protein αE-Catenin (Ctnna). To address this, we used a gene-trap line that expresses αE-Catenin-Citrine (Ctnna-Citrine) from the *ctnna* locus ([@bib45]; [@bib52]). In this line an artificial exon containing the *Citrine* coding sequence flanked by a splice donor and a splice acceptor is inserted between the exons 7 and 8 of the *ctnna* gene ([@bib52]). Homozygous *ctnna:ctnna-Citrine* fish are viable, indicating that Ctnna-Citrine is functional ([@bib45]). We generated *hsp70l:zGrad; ctnna:ctnna-Citrine/+* embryos and *ctnna:ctnna-Citrine/+* control embryos and heat shocked these embryos at 31 hpf for 30 min and imaged the embryos for 8 hr ([Figure 2I](#fig2){ref-type="fig"}). In contrast to heat-shocked control embryos, Ctnna-Citrine was degraded in zGrad-expressing embryos ([Figure 2J,K](#fig2){ref-type="fig"}). Since Ctnna tagged with a red fluorescent protein is not available, we could not perform a ratiometric analysis and instead quantified the total Ctnna-Citrine fluorescent intensity. This analysis showed that the time for onset of degradation of Ctnna-Citrine was 65 min and that Ctnna-Citrine was degraded by 58% with a half-life of 19 min in zGrad-expressing embryos ([Figure 2K](#fig2){ref-type="fig"}, [Table 1](#table1){ref-type="table"}).

Finally, we tested whether zGrad degrades GFP targeted to the secretory pathway by a signal peptide. Using fish that express secreted EGFP and secreted mCherry from a heat shock promoter (*hsp70l:sec-GFP; hsp70:sec-mCherry*), we generated *hsp70l:sec-GFP; hsp70:sec-mCherry; hsp70l:zGrad* embryos and *hsp70l:sec-GFP; hsp70:sec-mCherry* control embryos. Unlike H2A-EGFP, Cdh1-sfGFP and Ctnna-Citrine, expression of zGrad did not degrade secreted GFP ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}).

Together, these observations indicate that zGrad targets nuclear, cytoplasmic, and transmembrane proteins tagged with EGFP or Citrine for degradation.

zGrad-mediated protein degradation results in loss-of-protein function {#s2-3}
----------------------------------------------------------------------

Since zGrad efficiently degrades proteins from different cellular compartments ([Figure 2](#fig2){ref-type="fig"}), we asked whether we can use zGrad-mediated protein depletion to replicate known loss of protein function phenotypes and uncover novel ones. We addressed this question in several ways. First, we tested whether zGrad degrades cytoplasmic Ctnna-Citrine to disrupt its function in cell-cell adhesion ([@bib27]) using the *ctnna:ctnna-Citrine* gene trap line. We injected *zGrad* mRNA or *sfGFP* control mRNA into one-cell stage embryos that were maternal-zygotic Ctnna-Citrine (*MZ ctnna:ctnna-Citrine*, [Figure 3A](#fig3){ref-type="fig"}), maternal Ctnna-Citrine (*M ctnna:ctnna-Citrine*, [Figure 3D](#fig3){ref-type="fig"}) or zygotic Ctnna-Citrine (*Z ctnna:ctnna-Citrine*, [Figure 3G](#fig3){ref-type="fig"}). In *zGrad* mRNA-injected *MZ ctnna:ctnna-Citrine* and *M ctnna:ctnna-Citrine* embryos the cells started to become detached and partly shed from the embryo resulting in embryonic lethality around 3 to 5 hpf ([Figure 3B,C,E,F](#fig3){ref-type="fig"}). Control embryos injected with *sfGFP* mRNA developed normally ([Figure 3B,C,E,F](#fig3){ref-type="fig"}). Similarly but delayed by 20 hr, in *zGrad* mRNA-injected *Z ctnna:ctnna-Citrine* embryos, cells detached from the embryo by 24 hpf and about half of the embryos died (note, half the embryos were zygotically homozygous for *ctnna:ctnna-Citrine* since we crossed *ctnna:ctnna-Citrine*/*ctnna:ctnna-Citrine* males to *ctnna:ctnna-Citrine*/+ females, [Figure 3G,H,I](#fig3){ref-type="fig"}) while control injected embryos were unaffected ([Figure 3H,I](#fig3){ref-type="fig"}). The observed phenotype in *Z ctnna:ctnna-Citrine* embryos injected with *zGrad* mRNA is similar to the defects reported for zygotic *ctnna*-/- embryos ([@bib17]). Thus, zGrad depletes Ctnna-Citrine to levels too low to sustain cell-cell adhesion and embryonic development. Moreover, it suggests that maternally supplied Ctnna can sustain cell-cell adhesion and embryonic development for about 1 day before the embryo requires zygotic Ctnna.

![zGrad-mediated depletion of alpha-Catenin results in cell adhesion defects.\
(**A**) Breeding strategy to assess zGrad-mediated degradation of maternally and zygotically provided Ctnna-Citrine on embryonic development. (**B**) Images of MZ *ctnna:ctnna-Citrine* embryos injected with *sfGFP* control mRNA (left) or *zGrad* mRNA (right). Scale bar: 100 µm. (**C**) Quantification of MZ *ctnna:ctnna-Citrine* embryos injected with *sfGFP* control mRNA or *zGrad* mRNA that disintegrated and died. (**D**) Breeding strategy to assess zGrad-mediated degradation of maternally provided Ctnna-Citrine on embryonic development. (**E**) Images of M *ctnna:ctnna-Citrine* embryos injected with *sfGFP* control mRNA (left) or *zGrad* mRNA (right). Scale bar: 100 µm. (**F**) Quantification of M *ctnna:ctnna-Citrine* embryos injected with *sfGFP* control mRNA or *zGrad* mRNA that disintegrated and died. (**G**) Breeding strategy to assess zGrad-mediated degradation of zygotically provided Ctnna-Citrine on embryonic development. (**H**) Images of Z *ctnna:ctnna-Citrine* embryos injected with *sfGFP* control mRNA (left) or *zGrad* mRNA (right). Scale bar: 100 µm. (**I**) Quantification of Z *ctnna:ctnna-Citrine* embryos injected with *sfGFP* control mRNA and *zGrad* mRNA that displayed tissue rupture (arrow) and died.](elife-43125-fig3){#fig3}

Second, we tested whether zGrad degrades transmembrane Cdh1-sfGFP efficiently enough to disrupt its function ([@bib50]; [@bib42]; [@bib30]) and uncover late requirements of Cdh1 in cell-cell adhesion. Such an analysis is currently not possible because *cdh1*-/- embryos die during late gastrulation stages ([@bib22]; [@bib23]; [@bib32]). To address this, we crossed *hsp70l:zGrad/+; cdh1+/-; cdh1:cdh1-sfGFP/+* fish to *cdh1+/-* fish and as a control *cdh1+/-; cdh1:cdh1-sfGFP/+* fish to *cdh1+/-* fish. We separated *cdh1:cdh1-sfGFP* transgenic from *cdh1:cdh1-sfGFP* non-transgenic embryos from both crosses and separately heat-shocked the embryos for 1 hr at 25 hpf ([Figure 4A](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). In contrast to control embryos which showed no visible defects ([Figure 4B,C](#fig4){ref-type="fig"}), we found *cdh1-/-; cdh1:cdh1-sfGFP/+; hsp70l:zGrad/+* embryos shed their skin and rapidly died ([Figure 4D](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}), consistent with the idea that zGrad-mediated Cdh1-sfGFP degradation disrupts the cell-cell adhesion between the skin cells of the embryos that lack endogenous Cdh1 function. We would like to note that the skin phenotype in embryos with depletion of Cdh1-sfGFP was not always fully penetrant ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). Depending on the stage and the duration of the heat shock, we believe that Cdh1-sfGFP is not always depleted to low enough levels to cause a cell-cell adhesion defect. In summary, these observations suggest that transient expression of zGrad can efficiently degrade GFP-tagged proteins and, if GFP-tagged proteins are depleted sufficiently, cause loss-of-protein function and uncover phenotypes past the initial requirements of essential proteins.

![zGrad-mediated depletion of Cadherin-1 at 25 hpf results in skin defects and lethality.\
(**A**) Breeding strategy to assess heat shock-induced zGrad-mediated degradation of Cdh1-sfGFP on embryonic development. (**B, C, D**) Images of *cdh1+/-; hsp70l:zgrad/+; cdh1:cdh1-sfGFP/+* control embryo (**B**), *cdh1-/-; cdh1:cdh1-sfGFP/+* control embryo (**C**) and *cdh1-/-; hsp70l:zGrad/+; cdh1:cdh1-sfGFP* embryo with skin defects (**D**) at 29 hpf. Embryos were heat shocked at 25 hpf for 1 hr. Scale bar: 200 µm. Insets in (**C, D**) are magnified images of the skin in the same embryos. Scale bar: 50 µm.](elife-43125-fig4){#fig4}

Third, we asked whether induction of zGrad can degrade the Sdf1 chemokine receptor Cxcr4b tagged with EGFP to temporarily disrupt its function as a guidance receptor for the migration of the primordium ([@bib15]; [@bib11]). For this, we heat shocked *hsp70l:zGrad; cxcr4b*-/-; *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p7* embryos and *cxcr4b*-/-; *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p7* control embryos at 28 hpf when the primordium has completed a third of its migration along the body of the embryo and recorded the levels of Cxcr4b-EGFP and the migration of the primordium by time lapse microscopy. Cxcr4b-EGFP expressed from the *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p7* transgene restores the migration of the primordium in *cxcr4b*-/- embryos and Kate2-CaaX expressed from an internal ribosomal entry site (IRES) serves as a marker for the primordium and an internal reference for how much Cxcr4b-EGFP is produced ([@bib46]; [@bib31]). This analysis showed that induction of zGrad degraded Cxcr4b-EGFP ([Figure 5A,B,E](#fig5){ref-type="fig"}) and resulted in rounded primordium morphology ([Figure 5A,C](#fig5){ref-type="fig"}) and stalled primordium migration ([Figure 5A,D,E](#fig5){ref-type="fig"}) 90 min after heat shock. After 120 min newly produced Cxcr4b-EGFP was detectable again and the primordium resumed its migration ([Figure 5A,E](#fig5){ref-type="fig"}, [Figure 5---Video 1](#fig5video1){ref-type="video"}). Thus, a pulse of zGrad expression can deplete Cxcr4b-EGFP to levels unable to sustain directed cell migration of the primordium. This suggests that temporal zGrad induction from the heat shock promoter can be used to induce reversible protein loss-of-function scenarios.

![A pulse of zGrad degrades Cxcr4b-GFP and stalls primordium migration transiently.\
(**A**) Maximum-projected confocal images of the primordia in heat-shocked *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p7; cxcr4b-/-* embryos transgenic for *hsp70l:zGrad* (lower panels) or not (upper panels) at indicated time in min after the end of heat shock (31 hpf). Scale bar: 50 µm. (**B**) Quantification of Cxcr4b-EGFP-to-Kate2-CaaX ratios in the primordia of control (blue) and zGrad-expressing embryos (red) after the end of heat shock in min. Mean and SD are indicated. (**C**) Quantification of circularity of the primordia of control (blue) and zGrad-expressing embryos (red) after the end of heat shock in min. Mean and SD are indicated. (**D**) Quantification of the cumulative primordium migration distance in control (blue) and zGrad-expressing embryos (red) after the end of heat shock in min. Mean and SD are indicated. Inset shows magnification of the 30 min to 240 min time interval. \*\*=p \< 0.01. (**E**) Kymograph of the primordia in heat-shocked *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p7; cxcr4b-/-* embryos transgenic for *hsp70l:zGrad* (bottom) or not (top). Cxcr4b-EGFP is shown in green and Kate2-CaaX in red. Asterisk indicates the time interval in which Cxcr4b-EGFP is transiently degraded and the primordium transiently ceases to migrate.](elife-43125-fig5){#fig5}

Fourth, we asked whether tissue-specific expression of zGrad from the *cxcr4b* promoter can degrade Cxcr4b-EGFP and recapitulate the *cxcr4b* mutant primordium migration phenotype ([@bib15]). To address this question, we expressed zGrad from a 69 kb genomic fragment spanning the *cxcr4b* locus (*cxcr4b:zGrad*) ([Figure 6A](#fig6){ref-type="fig"}). The expression pattern of *zGrad* mRNA in *cxcr4b:zGrad* embryos faithfully recapitulated the *cxcr4b* mRNA expression pattern ([Figure 6B](#fig6){ref-type="fig"}). We crossed this line into the *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p1; cxcr4b-/-* background and determined the degree of Cxcr4b-EGFP degradation compared to Kate2-CaaX expression in primordia of *cxcr4b:zGrad* embryos and control embryos. Similar to the *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p7* transgenic line used above, the *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p1* fully restores primordium migration in *cxcr4b* mutant embryos, however, it expresses Cxcr4b-EGFP at two-fold lower levels ([@bib12]). This analysis showed that zGrad efficiently depleted Cxcr4b-EGFP below detectable levels ([Figure 6C,D](#fig6){ref-type="fig"}). Next, we assessed the primordium migration by staining for *cxcr4b* mRNA at 38 hpf. In *cxcr4b* mutant control embryos that carried the rescuing *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p1* transgene but lacked the *cxcr4b:zGrad* transgene, the primordium completed its migration and deposited the same number of neuromasts with the same spacing as in wild-type embryos ([Figure 6E,F](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). In contrast, embryos with the *cxcr4b:zGrad* transgene migrated on average only 72.5% of the distance ([Figure 6E,F](#fig6){ref-type="fig"}). Compared to primordia in *cxcr4b*-/- embryos, which showed little to no directed migration ([Figure 6E,F](#fig6){ref-type="fig"}) ([@bib15]), primordia in *cxcr4b*-/-; *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p1; cxcr4b:zGrad* embryos migrated directionally but at reduced speed, did not fully complete their migration and failed to deposit the terminal neuromasts by 4 dpf ([Figure 6E,F](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1B,C](#fig6s1){ref-type="fig"}). Importantly, expression of zGrad in the primordium did not affect its migration ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). This suggests that zGrad expression from the *cxcr4b* promoter efficiently degrades Cxcr4b-EGFP to levels low enough to slow primordium migration but not low enough to recapitulate the primordium migration defect observed in embryos with loss of Cxcr4b function, probably because the *cxcr4b* promoter does not express zGrad at high enough levels for complete degradation of Cxcr4b-EGFP driven from the same promoter. More generally, these observations indicate that expression of zGrad from a tissue-specific promoter can result in efficient degradation of GFP-tagged proteins to levels low enough to perturb protein function and cause tissue-specific defects.

![Tissue-specific expression of zGrad in the primordium degrades Cxcr4b-EGFP and slows down primordium migration.\
(**A**) Schematic of strategy to assess zGrad-mediated Cxcr4b-EGFP degradation in the primordium on primordium migration. (**B**) In situ hybridization against *cxcr4b* mRNA in a wildtype embryo and against *zGrad* mRNA in a *cxcr4b:zGrad* embryo at 24hpf. Scale bar: 0.5 mm. (**C**) Single-plane confocal images of the primordium in *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p1* control (left) and *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p1; cxcr4b:zGrad* embryos (right) at 36 hpf. Note that the embryos are *cxcr4b* +/- or *cxcr4b -/-*. Scale bar: 50 µm. (**D**) Quantification of Cxcr4b-EGFP to Kate2-CaaX fluorescence intensity ratio in the primordia of control embryos (blue) and embryos expressing zGrad in the primordium at 36 hpf. Mean and SD are indicated. \*\*=p \< 0.01. (**E**) In situ hybridization against *cxcr4b* mRNA in *cxcr4b*-/+ (top left), *cxcr4b*-/- (top right), *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p1; cxcr4b-/-* (bottom left) and *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p1; cxcr4b-/-; cxcr4b:zGrad* embryos (bottom right) at 38 hpf. Arrows indicate the location of the primordium. Scale bar: 0.5 mm. (**F**) Quantification of primordia migration distance of the indicated genotypes at 38 hpf. Mean, SD and n are indicated. \*\*=p \< 0.01, N.S. = p \> 0.05.](elife-43125-fig6){#fig6}

Discussion {#s3}
==========

In our study, we sought to develop a tool that allows for the acute inactivation of proteins in zebrafish. We modified the anti-GFP nanobody-based deGradFP system from flies ([@bib4]) and adapted it to zebrafish and named it zGrad. zGrad efficiently degrades GFP-tagged transmembrane, cytoplasmic and nuclear proteins. It recognizes different GFP versions (EGFP, sfGFP and Citrine, [Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}) and targets the tagged proteins for degradation. In contrast to other degron systems ([@bib36]) and similar to deGradFP ([@bib6]), zGrad degraded proteins tagged at the N-terminus, embedded within the protein and at the C-terminus in the examples reported here ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). We found that zGrad rapidly degrades GFP-tagged proteins with half-lives of around 20 min for transmembrane and cytoplasmic proteins ([Figure 2](#fig2){ref-type="fig"} and [Table 1](#table1){ref-type="table"}). These kinetics are similar to the kinetics reported for other degron-based systems ([@bib10]; [@bib38]; [@bib1]). The degradation of H2A-EGFP was significantly slower displaying a half-life of about 2.5 hr ([Figure 2](#fig2){ref-type="fig"} and [Table 1](#table1){ref-type="table"}). This could be due to the long life-time of histone proteins ([@bib9]) and the possibility that protein degradation is less efficient in nuclei. Importantly, in our system zGrad expression needs to be induced. This delays the onset of degradation by 65 to 200 min for the proteins we investigated. Nevertheless, zGrad degrades proteins rapidly enough to assess the consequences of abrupt protein inactivation.

Recently, the AID system was combined with the deGradFP system by fusing AID to the vhhGFP4 anti-GFP nanobody and shown to degrade GFP-tagged proteins in an auxin-dependent manner in zebrafish ([@bib10]). This elegant approach adds temporal control to the spatial control provided by the deGradFP system. Also, the fusion of AID to the vhhGFP4 nanobody overcomes the leakiness that we observed with the AID system ([@bib10]). However, compared to zGrad system, which requires the fusion of the protein of interest to GFP and the expression of zGrad, the mAID-nanobody system requires the expression of an additional component, the mAID-nanobody fusion protein -- a feature that adds more versatility but also requires additional effort.

One simple use of zGrad is the study of the contribution of maternally supplied proteins in early development. Depletion of maternal proteins by expressing zGrad from injected mRNA or as purified protein should uncover early protein requirements and can circumvent the laborious process of generating maternal mutants for essential genes by germline replacement ([@bib8]). Our finding that the depletion of maternal Ctnna results in an early and severe cell-cell adhesion defect is consistent with this idea ([Figure 3](#fig3){ref-type="fig"}). Alternatively, a pulse of zGrad should allow one to dissect the temporal requirements of proteins. Depending on the protein function this could result in a reversible phenotype as observed when we transiently stalled the migration of the primordium by depleting Cxcr4b ([Figure 5](#fig5){ref-type="fig"}) or to an irreversible phenotype if the function of the protein is continually required for viability as observed when we depleted Cdh1 and disrupted the integrity of the embryo ([Figure 4](#fig4){ref-type="fig"}). Another use of zGrad is to deplete proteins from certain tissues. By expressing zGrad from tissue-specific promoters, one can circumvent essential early requirements, assess later protein functions and disentangle the contribution of tissues to complex phenotypes. Our observation that depletion of Cxcr4b in the primordium by expressing zGrad from the *cxcr4b* promoter results in slowed migration supports this idea ([Figure 6](#fig6){ref-type="fig"}).

An important consideration is that zGrad needs to be expressed at high enough levels to deplete proteins to sufficiently low levels to fully disrupt protein function. One way to achieve high and tissue-specific zGrad expression is to amplify the production of zGrad through such systems as Gal4/UAS ([@bib40]) or -- to also add temporal control -- inducible systems such as the Tet-On system ([@bib5]). Such modifications combined with the increasing number of GFP-tagged transgenic ([@bib45]; [@bib24]) and knock-in lines ([@bib19]) should render zGrad as a useful tool for the study of the consequences of acute loss-of-protein function in zebrafish, possibly also circumventing the problem of genetic compensation observed in studies of genetic mutants ([@bib39]).

Materials and methods {#s4}
=====================

Zebrafish strains {#s4-1}
-----------------

Embryos were staged as previously described ([@bib25]). Hours post fertilization (hpf) was used to determine the developmental age of the embryos. Embryos were incubated at 28.5°C from one-cell-stage (0 hpf) until the indicated time. *cxcr4b^t26035^* ([@bib26]) homozygous mutant embryos were generated by inbreeding heterozygous adults, crossing homozygous adult with heterozygous adults or inbreeding homozygous adults. *tg(cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX)* ([@bib46]; [@bib31]) embryos were generated by crossing heterozygous adults with wild-type adults and sorted by GFP expression. *Gt(ctnna-citrine)Ct3a* ([@bib45]; [@bib52]) lines were maintained by inbreeding of heterozygous adults or homozygous adults. *cdh1*(*tx230*) ([@bib22]) were kept as heterozygous adults and *cdh1* homozygous embryos were generated by inbreeding heterozygous adults. The *hsp70:sec-mCherry* ([@bib48]), *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p1* ([@bib31]), *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p7* ([@bib46]), *cxcr4b:h2a-EGFP* ([@bib28]) and *cxcr4b:h2a-mCherry* ([@bib48]) were previously described. Zebrafish were maintained under the approval from IACUC (protocol number: 170105--02).

Generation of transgenic animals  {#s4-2}
---------------------------------

### hsp70l:zGrad-IRES-h2a-TagBFP  {#s4-2-1}

*zGrad*, *IRES-h2a* and *TagBFP* sequences were amplified by PCR and cloned into the plasmid *pDEST-tol2-hsp70l* ([@bib29]) by Gibson assembly ([@bib13]). *pDEST-tol2-hsp70l* contains a genomic fragment spanning 1.5 kb upstream of the *hsp70l* start codon ([@bib16]). 50 ng/µl of the *pDEST-tol2-hsp70l-zGrad-IRES-TagBFP* plasmid was co-injected with 25 ng/µl *tol2* mRNA into one-cell-stage embryos. Founder fish were identified by in situ hybridization against *vhhgfp4* sequence of heat-shocked offspring. Briefly, adult fish that were injected as embryos were outcrossed with wild-type adults and embryos were collected. At the shield stage, the embryos were heat-shocked at 39.5°C for 30 min. Preparation of the antisense RNA probe and whole-mount in situ hybridization were performed as previously described ([@bib26]). Fish that gave rise to *hsp70l:zGrad-IRES-H2A-TagBFP* offspring were kept as founder fish. zGrad activity was confirmed by heat shocking *hsp70l:zGrad-IRES-H2A-TagBFP; cxcr4b:h2a-EGFP* embryos and observation of H2A-GFP degradation. The line from the founder that showed the strongest GFP degradation was kept and used in this study. The full name of this line is *tg(hsp70l:zGrad-IRES-h2a-TagBFP)p1.* Note H2A-TagBFP expression from the IRES is not detectable in this line.

### cxcr4b:zGrad-IRES-h2a-TagBFP {#s4-2-2}

For the *cxcr4b:zGrad-IRES-h2a-TagBFP* BAC transgene, we used the BAC clone DKEY-169F10 ([@bib43]). This BAC clone contains the *cxcr4b* locus. We modified this BAC in two ways by recombineering. First, we modified *pBS-IndHom-Tol2-FRT-GalK-cryaa-dsRed* (Addgene plasmid \# 73203 ([@bib12])) by replacing the *cryaa:dsRed* sequence with *myl7:mScarlet* and the *FRT-GalK-FRT* sequence with the *kanR* sequence. The *myl7* (synonym *cmlc2*) promoter drives expression in the myocardium ([@bib21]) and *kanR* allows for rapid kanamycin-based selection of recombinants. The full name of this plasmid is *pBS-IndHom-Tol2(exon4)-Kan-Tol2(exon1)- myl7:mScarlet-Hom*. We amplified *Tol2(exon4)-Kan-Tol2(exon1)- myl7:mScarlet* cassette by PCR and inserted it into the *pIndigoBAC-5* backbone of the DKEY-169F10 BAC clone using *kanamycin* as a selection marker. Second, a cassette containing *zGrad-IRES-h2a-TagBFP-FRT-galK-FRT* flanked by homology arms upstream of the *cxcr4b* exon2 and downstream of the *cxcr4b* stop codon was inserted to replace the *cxcr4b* coding sequence in exon2 using *galK* as a selection marker. The *galK* cassette was removed by Flippase. The obtained BAC was characterized with sequencing the modified region in the BAC and EcoRI finger printing. This transgene expresses zGrad-IRES-H2A-TagBFP fused to five amino acids from *cxcr4b* exon1 under the *cxcr4b* promoter. The BAC was prepared with the nucleobond BAC 100 kit (Clonetech) and co-injected with 25 ng/µl *tol2* mRNA into one-cell-stage embryos. Stable transgenic animals were identified by out-crossing injected adults and screening for the red hearts in 4 dpf larvae. Embryos were collected from each stable transgenic fish and tested for expression of *zGrad* by whole mount in situ hybridization 30 hpf. We selected the transgenic line that expressed the highest level of *zGrad* from the BAC transgene and used it in this study. The full name of this transgenic line is *TgBAC(cxcr4b:zGrad-IRES-h2a-TagBFP)p3*. Note H2A-TagBFP expression from the IRES is not detectable in this line.

For the *hsp70l:sec-GFP* transgene, the *pDestTol2pA-hsp70l-anos1b-sv40pA* plasmid was used as a template ([@bib48]). Using Gibson cloning ([@bib13]), we replaced the *anos1b* coding sequence with the coding sequence of *GFP* fused to the 3' end of the *fgf3* secretion signal (amino acids 1 to 18). We verified the final construct by sequencing and co-injected it along with *tol2* transposase mRNA into zebrafish embryos at the one-cell stage. Stable transgenic fish were identified by out-crossing adults injected with the transgene and raising larvae from fish whose offspring were identified to express GFP upon heat shock as determined by green fluorescence. Founder fish were verified to carry a single copy of the transgene by determining the fraction of progeny carrying the transgene. The full name of this transgenic line is *Tg(hsp70l:sec-GFP)p1*.

### *cdh1:cdh1-sfGFP* and *cdh1:cdh1-TagRFP* lines {#s4-2-3}

For the *cdh1:cdh1-sfGFP* and *cdh1:cdh1-TagRFP* BAC transgenes, we used the BAC clone CHORI-211--175 C23. This BAC clone spans 72 kb of genomic sequence and contains the *cdh1* locus and was modified in two ways by recombineering. First, the *Tol2* sites and the *cryaa:Cerulean* transgenesis marker were inserted into the BAC backbone ([@bib12]). Second, a cassette consisting of *sfGFP-FRT-galK-FRT* or *TagRFP-FRT-galK-FRT* flanked by 446 bp and 590 bp of homology upstream of the stop codon in *cdh1* exon 16, and downstream of the stop codon in *cdh1* exon 16, respectively, was inserted before the *cdh1* stop codon using galK-mediated recombineering ([@bib49]). The galK cassette was removed by Flippase-mediated recombination. This transgene expresses the full length of Cdh1 fused to sfGFP or TagRFP from the *cdh1* promoter. The final BAC transgenes were characterized by EcoRI restriction digestion and sequencing of PCR amplicons of the modified locus. The CHORI-211--175 C23 BAC clone was obtained from BACPAC Resources, Children\' Hospital Oakland Research Institute, CA (bacpacorders\@chori.org). The BACs were purified with the nucleobond BAC 100 kit (Clontech). We co-injected 1 nl of 40 ng/µl *Tol2* mRNA and 50--250 ng/µl of the *cdh1:cdh1-sfGFP* or *cdh1:cdh1-TagRFP* BAC transgene DNA into the lifting cell of the zygote of 0 to 20 min old embryos. The *Tol2* mRNA was transcribed from the pCS2FA-transposase plasmid ([@bib29]) using the mMessage mMachine SP6 Transcription Kit (Thermo Fisher). Stable transgenic larvae were identified by out-crossing adults injected with the *cdh1:cdh1-sfGFP* or *cdh1:cdh1-TagRFP* BAC transgenes, and by raising larvae positive for the blue fluorescent transgenesis marker in the lens of the eye at 4 dpf. The full names of these two transgenic lines are *TgBAC(cdh1:cdh1-sfGFP)p1* and *TgBAC(cdh1:cdh1-TagRFP)p1*.

All transgenic lines generated for this study are available upon request.

Generation of plasmids for in vitro transcription {#s4-3}
-------------------------------------------------

To construct *pCS2+-mScarlet-V5*, the *mScarlet* coding sequence was amplified from *pmScarlet-C1* (Addgene plasmid \# 85042, ([@bib2])) by PCR with a 5' primer containing V5-tag sequence and cloned into *pCS2+* plasmid by Gibson assembly. To construct *pCS2+-sfGFP*, *sfGFP* coding sequence was amplified by PCR and cloned into *pCS2+* plasmid by Gibson assembly.

To construct *pCS2+-Nslmb-vhhGFP4*, *Nslmb-vhhGFP4* coding sequence was amplified from *pcDNA3-NSlmb-vhhGFP4* (Addgene plasmid \#35579, ([@bib6])) by PCR and cloned into *pCS2+* plasmid by Gibson assembly.

To construct *pCS2+-OsTIR1-mCherry*, the *OsTIR1* and *mCherry* coding sequences were amplified from *pMK232-CMV-OsTIR1-PURO* (Addgene plasmid \#72834, ([@bib35])) and *pCS2+-lyn~2~mCherry* (kind gift from Reinhard Köster and Scott Fraser) respectively, by PCR and cloned into *pCS2+* plasmid by Gibson assembly.

To construct *pCS2+-sfGFP-mAID*, the *sfGFP* coding sequence was amplified by PCR and the mAID tag sequence ([@bib33]) was generated by primer annealing and cloned into *pCS2+* plasmid by Gibson assembly.

To construct *pCS2+-fbxw11b-vhhGFP* (*pCS2+-zGrad*), the coding sequence for the N-terminal 217 amino acids of Fbxw11b was amplified by PCR from cDNA of 36 hpf embryos, fused to the *vhhGFP4* coding sequence and inserted into the *pCS2+* plasmid by Gibson assembly. This plasmid is available from addgene (plasmid \#119716).

To construct *pCS2+-zif-1*, the coding sequence of *zif-1* was codon optimized for zebrafish by gene synthesis (IDT) and inserted into the *pCS2+* plasmid by Gibson assembly.

To construct *pCS2+-sfGFP-ZF1*, the coding sequence of *ZF1* was codon optimized for zebrafish by gene synthesis (IDT) and inserted together with *sfGFP* into the *pCS2+* plasmid by Gibson assembly.

The *pCS2+-vhhGFP4-hSPOP* and *pCS2+-vhhGFPmut-hSPOP* plasmids were previously described ([@bib41]) and kindly gifted by Byung Joon Hwang.

mRNA injection {#s4-4}
--------------

Templates for in vitro mRNA transcription were generated by PCR or restriction digest of mRNA expression plasmids. mRNAs were transcribed using the mMESSAGE mMACHINE SP6 transcription Kit (Thermo Fisher Scientific). Injection mixes contained 50 ng/µl mRNAs except for the mAID experiment, where *OsTIR1-mCherry* mRNA was prepared as 10 ng/µl, 5 ng/µl and 1 ng/µl, with 0.1% Phenol Red Solution (LIFE TECHNOLOGIES). The injection mix was injected in one-cell-stage embryos. The quality of the mRNA was assessed post injection through gel electrophoresis using the remaining mix in the injection needle.

Auxin-inducible degradation {#s4-5}
---------------------------

Natural auxin 3-Indoleacetic acid (IAA, Sigma Aldrich) was dissolved in 100% ethanol at a concentration of 250 mM, protected from light and stored at −20°C. Injected embryos were raised in fish water (4 g/l instant ocean salt) without Methylene blue to avoid possible interference from the dye. 50 ng/µl *sfGFP-mAID* mRNA was co-injected with 10 ng/µl, 5 ng/µl or 1 ng/µl *OsTIR1-mCherry* mRNA. Injected embryos were dechorionated manually. At 8 hpf IAA was added to 500 µM final concentration ([@bib10]; [@bib51]). Images were taken on a Leica 165M FC Fluorescent Stereo Microscope equipped with a Leica DFC345 FX camera every hour for 3 hr.

Image acquisition and quantification of mRNA-injected embryos {#s4-6}
-------------------------------------------------------------

To quantify the ratio of sfGFP-ZF1 fluorescence to mScarlet-V5 fluorescence, injected embryos were dechorionated manually or by adding Pronase (Sigma Aldrich) to 0.3 mg/ml on petri dishes coated with 2% agarose in fish water at 9 hpf. Injected embryos were mounted in 0.5% low-melt agarose (National Diagnostics)/Ringer's solution (MgSO4 0.6 mM, CaCl2 1 mM, KCl 5 mM, NaCl 111 mM, HEPES 5 mM) on a slide. Mounted embryos were imaged on Leica SP5 II confocal microscope equipped with HyD detectors (Leica Microsystems) using a Leica 20x (NA 0.7) objective and a Leica 40x water immersion lens (NA 1.1) in the case of Ab-SPOP-mediated GFP degradation.

All images were collected in the photon-counting mode with identical microscope settings. Quantification of signal intensity from injected embryos was performed using a custom-written ImageJ macro ([Source code 1](#scode1){ref-type="supplementary-material"}). Briefly, the macro selects a single Z-slice and generates a mask based on the mScarlet intensities using the Otsu thresholding algorithm. The mScarlet mask is then applied to the green and red channels of the same Z-slice to extract average GFP and mScarlet signal intensities only from the masked region. These procedures are repeated on the whole Z-stack. Average signal intensities from the first 40 Z-slices (62 µm) starting at the animal pole were used to calculate the green-to-red fluorescence intensity ratio of an embryo. The sfGFP-ZF1/mScarlet-V5 fluorescence intensity ratios for Ab-SPOP-mediated GFP degradation were calculated manually using ImageJ. Briefly, five nuclei per embryo were outlined and the average nuclear signal intensities in the green and red channels was extracted and used for the calculation of the green-to-red fluorescence intensity ratios in the nuclei. For quantification of signal intensities in the cytoplasm, a 20 × 20 pixels (3.79 µm x 3.79 µm) region was manually selected and the average signal intensities in the green and red channels were extracted to calculate the green-to-red fluorescence intensity ratio. The regions from five cells per embryo for five embryos were analyzed for each condition. The overview fluorescence images in [Figure 1D](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"} (AID) were collected on Leica 165M FC Fluorescent Stereo Microscope equipped with a Leica DFC345 FX camera.

Heat-shock regimens {#s4-7}
-------------------

To determine the degradation kinetics of H2A-EGFP, *cxcr4b:h2a-EGFP; cxcr4b:h2a-mCherry* embryos with and without the *hsp70l:zGrad-IRES-h2a-TagBFP* transgene were heat shocked around 29--30 hpf at 39.5°C for 1 hr in a water bath, mounted in the 0.5% low-melt agarose/Ringer's solution with 0.4 mg/ml MS-222 anesthetic and imaged 80 min after the end of heat shock every 10 min for 9.5 hr on a Leica SP5 II confocal microscope equipped with HyD detectors (Leica Microsystems) using a 20x (NA 0.5) objective. Laser power was calibrated to 30 µW for 488 and 120 µW for 561. Pinhole was set to 85 µm.

To determine the degradation kinetics of Cdh1-sfGFP, *cdh1:cdh1-sfGFP; cdh1:cdh1-TagRFP* embryos with and without the *hsp70l:zGrad-IRES-h2a-TagBFP* transgene were mounted in the 0.5% low-melt agarose/Ringer's solution with 0.4 mg/ml MS-222 anesthetic, heat shocked around 31 hpf at 39.5°C for 30 min in a water bath and imaged 35 min after the end of heat shock every 10 min for 4.8 hr on a Leica SP5 II confocal microscope equipped with HyD detectors (Leica Microsystems) using a 40x (NA 0.8) objective. The laser power was calibrated to 32 µW for the 488 nm laser line and 115 µW for the 594 nm laser line. The pinhole was set to 230 µm.

To determine the degradation kinetics of Ctnna-Citrine, *ctnna:ctnna-Citrine/+* embryos with or without the *hsp70l:zGrad-IRES-h2a-TagBFP* transgene were mounted in the 0.5% low-melt agarose/Ringer's solution with 0.4 mg/ml MS-222 anesthetic, heat shocked around 31 hpf at 39.5°C for 30 min in a water bath and imaged 35 min after the end of the heat shock every 20 min for 8 hr on a Leica SP8 confocal microscope equipped with HyD detectors (Leica Microsystems) using a 40x (NA 0.8) objective. The laser power was set to 31 µW for the 488 nm laser line. The pinhole was set to 106 µm. All imaged embryos were genotyped for *hsp70l:zGrad-IRES-h2a-TagBFP* by PCR.

To test the degradation of Sec-GFP by zGrad, *hsp70l:sec-GFP; hsp70:sec-mCherry* with and without the *hsp70l:zGrad-IRES-h2a-TagBFP* transgene were heat shocked around 24 hpf at 39.5°C for 1 hr in a water bath. Embryos were imaged at 30 hpf with a Leica 165M FC Fluorescent Stereo Microscope equipped with a Leica DFC345 FX camera. Imaged embryos were digested and genotyped for *hsp70l:zGrad-IRES-h2a-TagBFP* by PCR.

To observe the consequences of transient loss of Cxcr4b function, *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p7; cxcr4b -/-* embryos with and without the *hsp70l:zGrad-IRES-h2a-TagBFP* transgene were heat shocked at 31 hpf and 39.5°C for 1 hr in a water bath and imaged 30 min after the end of the heat shock every 20 min for 8 hr on a Leica SP8 confocal microscope equipped with HyD detectors (Leica Microsystems) using a 20x (NA 0.5) objective. The laser power was adjusted to 31 µW for the 488 nm laser line and to 73 µW for 594 nm laser line. The pinhole was set to 85 µm. Imaged embryos were genotyped for *hsp70l:zGrad-IRES-h2a-TagBFP* by PCR as described below.

Analysis of the degradation kinetics after heat shock {#s4-8}
-----------------------------------------------------

Quantification of signal intensity from heat shocked embryos was performed using a custom-written ImageJ macro ([Source code 2](#scode2){ref-type="supplementary-material"}). For H2A-EGFP/H2A-mCherry ratio imaging, a region encompassing the primordium and the somites (100 × 50 pixels, 75.76 µm x 37.88 µm) was manually selected. The macro script duplicates the red channel, applies a Gaussian Blur (sigma = 1) and generates a mask based on the mCherry intensities using Renyi Entropy Thresholding algorithm for the primordium and the imageJ Default Thresholding for the somites. Then, the macro applies the mask on the green and red channels to extract H2A-EGFP and H2A-mCherry signal intensities only from the masked region. Then, the macro sum-projects the green and red channels and extracts mean intensities of H2A-EGFP and H2A-mCherry for each time point. Data from two independent imaging sessions were pooled for the analysis. Four embryos with *hsp70l:zGrad* transgene (two from each imaging session) and four embryos without *hsp70l:zGrad* transgene as control (two from each imaging session) were analyzed.

For Cdh1-sfGFP/Cdh1-TagRFP ratio imaging, first a region of 300 × 300 pixel (77.27 µm x 77.27 µm) at the center of the embryo was manually selected. The macro duplicates the red channel, applies a Gaussian Blur (sigma = 1) and generates a mask based on the TagRFP intensities using the imageJ Default Thresholding. Then, it applies the mask on the green and red channels to extract Cdh1-sfGFP and Cdh1-mCherry signal intensities only from the masked region. Then, the macro sum-projects the green and red channels and extracts the mean intensities of the Cdh1-sfGFP and Cdh1-TagRFP fluorescences for each time point. Three embryos with carrying the *hsp70l:zGrad* transgene and four control embryos without the *hsp70l:zGrad* transgene were analyzed.

For Ctnna-Citrine fluorescence intensity approximation, a region of 300 × 300 pixel (85.23 × 85.23 µm) at the center of the embryo was manually selected. The Z-stack comprising this region was maximum projected. The mean intensities of maximum-projected images were extracted over all time points. Four embryos with *hsp70l:zGrad* transgene and four embryos without *hsp70l:zGrad* transgene as control were analyzed.

For Cxcr4b-EGFP-to-Kate2-CaaX ratio imaging, the region of the primordium was manually selected and signal intensities were quantified using a custom-written ImageJ macro ([Source code 3](#scode3){ref-type="supplementary-material"}). Briefly, the macro script duplicates the red channel, applies a Gaussian Blur (sigma = 2), maximum-projects the Z-stack, generates a mask based on the Kate2 intensities using the imageJ Default Thresholding, fills holes, erodes and dilates once (erosion and dilation reduces noise). Then, the macro sum-projects the green and red channels and applies the mask to the green and red channels to extract Cxcr4b-EGFP and Kate2-CaaX signal intensities only from the masked regions for each time point. Five embryos with *hsp70l:zGrad* transgene and five embryos without *hsp70l:zGrad* transgene as control were analyzed.

Analysis of the circularity of the primordium {#s4-9}
---------------------------------------------

To quantify the morphology of the primordium, we defined the extension of the primordium as the first 100 µm from the tip of the primordium. Using Fiji, the primordium region was manually cropped in the red channel based on the Kate2-CaaX fluorescence intensities. Then, a median filter (six pixels) was applied and the background was subtracted. Images were rendered binary using the Huang thresholding algorithm to obtain clear outlines of the primordium. Finally, we quantified the circularity of the primordium for each time point using the 'Analyze Particles' macro in Fiji. The circularity is defined as *circularity = 4pi(area/perimeter\^2)*.

Cumulative migration distance and kymographs analysis {#s4-10}
-----------------------------------------------------

To quantify the migration distance of the primordium over time, the 'Manual Tracking' plugin by Fabrice Cordelieres in Fiji was used to track the tip of the primordium. Kymographs were drawn using the 'KymoResliceWide' plugin by [Eugene Katrukha](http://katpyxa.info) and Laurie Young in Fiji with a width of 5 pixel.

Image acquisition and quantification of zGrad-mediated Cxcr4b-EGFP degradation with zGrad expressed from the *cxcr4b* promoter *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p1* embryos and *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p1; cxcrb4:zGrad-IRES-h2a-TagBFP* embryos were sorted for the expression of the transgenesis marker (the *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p1* transgene expresses dsRed in the lens and the *cxcrb4:zGrad-IRES-h2a-TagBFP* transgene expresses mScarlet in the myocardium of the heart) at 29 hpf. Ten embryos of each genotype were mounted in 0.5% low-melt agarose/Ringer's solution with 0.4 mg/ml MS-222 anesthetic on a slide. Embryos were imaged at 33 to 34 hpf using a Leica SP8 confocal microscope equipped with HyD detectors (Leica Microsystems) using a 40x (NA 1.1) objective. The laser power was calibrated to 27 μW for the 488 nm laser line and 82 µW for the 594 nm laser line. The pinhole was set to 77.17 µm. To quantify the signal intensity ratio of EGFP/Kate2 in the primordium, the primordium was manually selected and fluorescent intensities for EGFP and Kate2 were extracted using the same custom-written ImageJ macro as described in the quantification of Cdh1-sfGFP degradation kinetics.

Degradation of Ctnna-Citrine by zGrad mRNA injection {#s4-11}
----------------------------------------------------

1--2 nl of 50 ng/µl of *zGrad* mRNA or 50 ng/µl of *sfGFP* mRNA were injected in one-cell stage zygotic, maternal and maternal zygotic *ctnna:ctnna-Citrine/ctnna:ctnna-Citrine* embryos. Possible degradation of the mRNA in the injection mix was assessed by electrophoresis of the injection mix in the needle after injection of the embryos. For imaging, the embryos were mounted in 0.5% low-melt agarose/Ringer's solution on a slide. Images of injected embryos were obtained using an Axioplan Microscope (Zeiss) equipped with an Axiocam (Zeiss) and a 10x (NA 0.5) objective for [Figure 3B and E](#fig3){ref-type="fig"} and a 5x (NA 0.25) objective for [Figure 3H](#fig3){ref-type="fig"}. The number of dead and alive embryos was scored at 24 hpf.

Genotyping of *cxcr4b^t26035^* and *hsp70l:zGrad-IRES-H2A-TagBFP* {#s4-12}
-----------------------------------------------------------------

To distinguish endogenous *cxcr4b-/+* and *cxcr4b-/-* from the *cxcr4b:cxcr4b-EGFP-IRES-kate2-CaaX* transgene in [Figure 6](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}, the following outer and nested primer pairs were used: forward outer primer: GCAGACCTCCTGTTTGTCC reverse outer primer: CTAAGTGCACACATACACACATT forward nested primer: TCGAGCATGGGTACCATC reverse nested primer: CTTAATCATCCATGTGGAAAAG.

The reverse primers are designed to anneal to 3'UTR of the *cxcr4b* gene so that *cxcr4b-EGFP-IRES-Kate2-CaaX* transgene will not be amplified due to its large size. The PCR product was digested with the restriction enzyme HpyAV (NEB) to distinguish heterozygous and homozygous mutants.

To genotype *hsp70l:zGrad-IRES-h2a-TagBFP*, the region between *hsp70l* promoter and *fbxw11b* was amplified by PCR using the following outer and nested primer pairs: forward outer primer: TGAGCATAATAACCATAAATACTA reverse outer primer: ACCAGTTGGACTTGATCCATATGTCGACCACACCTCCAG forward nested primer: AGCAAATGTCCTAAATGAAT reverse nested primer: CAGAGGTGTTCATCTGCTC.

Whole-mount in situ hybridization {#s4-13}
---------------------------------

The procedures for RNA probe synthesis and whole-mount in situ hybridization were done as previously described ([@bib44]). The RNA probe against *cxcr4b* was previously described ([@bib26]). The template for the synthesis of the in situ RNA probe against *vhhGFP4* was amplified from *pcDNA3-NSlmb-vhhGFP4* (Addgene plasmid \#35579) using the following primer pair: forward primer: ggccgtcgacATGATGAAAATGGAGACTGAC reverse primer: TAATACGACTCACTATAGGGTTAGCTGGAGACGGTGACCTG.

The template for the synthesis of the in situ RNA probe against *EGFP* was amplified using the following primer pair: forward primer: GTGAGCAAGGGCGAGGAGCTG reverse primer: gaaatTAATACGACTCACTATAgggCTTGTACAGCTCGTCCATGCC.

The template for the synthesis of the in situ RNA probe against *mCherry* was amplified using the following primer pair: forward primer: GTGAGCAAGGGCGAGGAGGACA reverse primer: gaaatTAATACGACTCACTATAgggCTTGTACAGCTCGTCCATGCCGCCGG.

The RNA probe was synthesized using the Roche DIG labeling mix (Roche) and detected with an anti-DIG antibody coupled to alkaline phosphatase (1:5000, Roche) and NBT/BCIP stain (Roche). Embryos were mounted in the 3% Methyl cellulose (Sigma Aldrich). Images were collected on a Axioplan Microscope (Zeiss) equipped with an Axiocam (Zeiss) using a 10x (NA 0.5) objective.

Quantification of the primordium migration distance {#s4-14}
---------------------------------------------------

*cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p1; cxcr4b-/+* fish were crossed to *cxcrb4:zGrad-IRES-h2a-TagBFP; cxcr4b-/-* fish and embryos were sorted based on the transgenesis markers (dsRed in lens for *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX-p1* and mScarlet in myocardium of heart for *cxcrb4:zGrad-IRES-h2a-TagBFP*) at 38 hpf and fixed in 4% PFA (Sigma Aldrich) in PBST overnight at room temperature. Whole-mount in situ hybridization against *cxcr4b* mRNA was performed as described above. Images for quantification of migration distance were taken in PBST on an Axioplan Microscope (Zeiss) equipped with an Axiocam (Zeiss) using a 10x (NA 0.5) objective. Both sides of the embryo were imaged and counted as individual replicates. Images for [Figure 6E](#fig6){ref-type="fig"} were taken by mounting embryos in 3% Methyl cellulose. *cxcr4b* mutant embryos were genotyped by PCR after image acquisition. The migrating distance of the primordium was quantified manually using ImageJ.

Conditional Cdh1 loss-of-protein function through zGrad expression from a heat-shock promoter {#s4-15}
---------------------------------------------------------------------------------------------

The number of embryos from *cdh1:cdh1-sfGFP/+; cdh1+/-* with or without *hsp70l:zGrad* females crossed with *cdh1+/-* males was counted at 5 hpf. The dead embryos were removed at 24 hpf and embryos were sorted by Cdh1-sfGFP expression. At 25 hpf, embryos were heat shocked at 39.5°C for 1 hr in a water bath. The embryos were mounted in 0.5% low-melt agarose/Ringer's solution on a plastic dish filled with Ringer's solution which was supplemented with 0.4 mg/ml MS-222 anesthetic. Images of embryos were recorded with an Axioplan Microscope (Zeiss) equipped with an Axiocam (Zeiss) and a 5x (NA 0.25) objective (panels B, C and D in [Figure 4](#fig4){ref-type="fig"}) and a 10x (NA 0.5) objective (panels C and D insets in [Figure 4](#fig4){ref-type="fig"}). The number of embryos with and without skin defects and lethality was scored at 32 hpf. Embryos were transferred into TRIzol reagent (Thermo Fisher Scientific) to extract mRNA. mRNA was reverse transcribed into cDNA with the Super Script III First-Strand Synthesis System kit (Thermo Fisher Scientific). To distinguish cDNA from the endogenous *cdh1* mRNA and the transgenic *cdh1:cdh1-sfGFP* mRNA, the following outer and nested primer pairs were used: forward outer primer: CAATATAACAGGCTCTGGGCAGAT reverse outer primer: ATAAAAGAGTCTCATATTTTGC forward nested primer: GTCAAGAATGCTTTGGATCG reverse nested primer: AATCATTGAGCCTTTTGCACC.

Due to the short elongation time, these PCRs only amplified the cDNA from the endogenous *cdh1* locus. The PCR amplicons were purified with the QIAquick PCR Purification Kit (QIAGEN) and sequenced with the primer TGTCCGTTATAGAGAGAAGC. Genotyping for *hsp70l:zGrad* transgenic embryos was also done from cDNA by PCR with the following primer pair: forward primer: ATGGATCAAGTCCAACTGG reverse primer: TTAGCTGGAGACGGTGACCC.

DASPEI staining and neuromast position quantification {#s4-16}
-----------------------------------------------------

The location of neuromasts was assessed by staining 4 dpf live embryos with 25 ug/mL DASPEI (2-(4-(dimethylamino)styryl)-N-Ethylpyridinium Iodide, Invitrogen). Images were collected on Leica 165M FC Fluorescent Stereo Microscope equipped with a Leica DFC345 FX camera. The location of the last neuromast on the trunk was quantified as ratio between the length from the head to the last neuromast on the trunk divided by the length of the whole embryo (see [Figure 6---figure supplement 1B,C](#fig6s1){ref-type="fig"}).

Statistical analysis {#s4-17}
--------------------

Statistical tests were performed using R and R-studio software. To compare two sample sets, first each sample set was tested using the Kolmogorov-Smirnov test to determine whether the sample set was normally distributed. Then, we tested whether the sample sets had the same standard deviation using the F-test. Based on the result of F-test, the two sample sets were compared by either the Welch's t-test or the Student's t-test ([Figures 1H](#fig1){ref-type="fig"}, [6D and F](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1C](#fig6s1){ref-type="fig"}). To analyze the fold-change curves in [Figure 2C, E, H and K](#fig2){ref-type="fig"}, the curves were fitted to a one-exponential decay model (Y = Span\*exp(-k\*X)+Plateau) using Prism 7 (Graphpad). The values of T1/2 and the plateau, which we assumed to be the value of maximal degradation, were extracted from the fitted curves. In [Figure 5D](#fig5){ref-type="fig"} (inset, 30 min to 240 min), two data sets were compared by paired-t test using Prism.
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###### ImageJ macro to analyze intensity of GFP and RFP channels of images from mRNA-injected embryos.
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###### ImageJ macro to analyze signal intensity of the GFP and the RFP channel in time lapse movies from cxcr4b:h2a-EGFP; cxcr4b:h2a-mCherry embryos.
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###### ImageJ macro to analyze signal intensity of the GFP and the RFP channel in time lapse movies from Cxcr4b-EGFP-to-Kate2-CaaX embryos.
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Data availability {#s7}
-----------------

All data generated or analysed during this study are included in the manuscript and supporting files. Two main tables are provided: Table 1 as a detail numerical data set for supporting Cdh1 transgene is fully functional; Table 2 as detail numerical data set for protein degradation kinetics exported from fitting against the one-exponential decay model. Source code files 1-3 describe the custom Image J macros written to analyze data. The pCS2-zGrad plasmid is available from Addgene (<https://www.addgene.org/119716/>). Transgenic fish lines are available from our lab upon request to the corresponding author.
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Thank you for submitting your article \"zGrad is a nanobody-based degron system that inactivates proteins in zebrafish\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Didier Stainier as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Thomas F Schilling (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. There was broad agreement that your work would be suitable for *eLife* after the points raised below are addressed.

*Reviewer \#1:*

The manuscript submitted by Holger Knaut and colleagues for publication in *eLife* describes a novel approach to study protein function in zebrafish, a model system that has made major contribution to a better understanding of vertebrate development due to its ease to do live imaging studies at cellular resolution.

Upon testing a number of different degradation systems, the authors adapted a previously described method to degrade GFP-fusion proteins with a nanobody recognizing GFP, fused itself to a F-box of the *Drosophila* protein Slmb, targeting the GFP-fusion protein to the proteasome. Since the authors found that the *Drosophila* F-box did not lead to efficient degradation, they exchanged the latter with the F-box of the corresponding gene from zebrafish, and then showed that this construct is capable to degrade nuclear, transmembrane and cytoplasmic FP-tagged proteins. Most importantly, using endogenously tagged FP proteins, the authors showed that zGrad was capable to generate loss of function phenotypes in the zebrafish, opening the door to degrade proteins in a time- and tissue-dependent manner in unprecedented fashion. More importantly, protein degradation allows removing maternal contribution of the protein of interest (if a FP tagged rescue or endogenous version is available); this is particularly important for cell biological studies, since many widely expressed proteins are also maternally contributed.

The study is done very carefully and in a quantitative manner. This study was only possible since the authors had functional FP constructs of their genes of interest.

*Reviewer \#2:*

In this paper the authors report their development of a nanobody-based method for targeted protein degradation in zebrafish. They show that by adapting a deGradFP system used in *Drosophila* they can obtain efficient degradation of nuclear, cytoplasmic and transmembrane proteins in both a temporally- and spatially-controlled manner, while other similar degradation systems are less effective. They confirm that using this zGrad system they can obtain previously published loss-of-function phenotypes for E-cadherin, E-catenin and Cxcr4b. They then go beyond previous mutant studies of these factors to address temporal requirements -- such as maternal versus zygotic functions of E-catenin, and Cxcr4b in collective migration of the lateral line primordium -- as well as tissue-specific promoters to disrupt Cxcr4b in specific cell types. This is a major technical advance, as tools for conditional loss-of-function approaches in zebrafish are desperately needed. The experiments are well designed, rigorously analyzed and the results are convincing. It is somewhat less innovative conceptually given the fact that a similar system exists in flies and functions of all of the genes examined here have been studied before. In addition, there are some concerns about variability in the effectiveness of zGrad and its reproducibility.

1\) The paper shows a wide variety of efficiencies in the reduction in levels as well as the timing of degradation for different zGrad target proteins. As proof of principle with sfGFP-ZF1 they co-inject one-cell stage embryos and assay protein levels 9 hours later (Figure 1). What are the results if assayed at 2-3 hpf? The authors argue that the system should work within that time frame. For H2A-EGFP the onset of degradation is estimated as 140-200 min while for Ctnna-Citrine it appears to be as early as 65 min. How do the authors account for these differences in onset?

2\) Experiments with H2A-EGFP show widely varied reductions in protein levels in different tissues, which the authors argue reflects different levels of endogenous H2A production. This raises the question of how functional experiments with proteins for which function is unknown can deal with the potential differences in efficiency introduced by variation in the synthesis of new protein? Negative results obtained with zGrad will be extremely hard to interpret. For Figure 2D-E the authors should confirm the hypothesis that the difference in degradation efficiency between somites and lateral line primordia is due to different expression levels of H2A-GFP with in situs for eGFP and mCherry.

3\) Variability in the effectiveness of zGrad for Cdh1 to cause cell adhesion defects is explained as being due to variability in zGrad levels. However again this complicates interpretation. Can zGrad levels be monitored and correlated with variability in phenotypic defects? The authors should genotype the embryos to identify those that are *cadh+/-;cdh1:cd1-sfgfp;hsp70l:zGrad* as the phenotype can only be visualized in these embryos.

4\) Interpretation of the results also depends to a great extent on what is co-injected in a given experiment, in terms of amount, and how long it persists in the embryo. This is particularly a potential problem in experiments addressing maternal versus zygotic function.

5\) The authors should compare the different deGradFP systems used in zebrafish more clearly either in the Introduction or Discussion section to help the reader appreciate the improvements in their system over the previous ones. Since the authors start with results from existing methods and show them in figure supplements, it would be helpful if they present their general experimental strategy including the model for the degron system in the first supplementary figure.

6\) Clarify the choice of the Slimb system over the *C. elegans* system, considering that both had similar efficiency of knockdown (19% and 17%).

7\) Clarify why the results shown in Figure 2---video 1 and Figure 5---video 1 are so similar -- slight delays in lateral line migration in zGrad expression embryos, which recover over time -- considering the difference in their backgrounds?

8\) Figure 3. The *ctnna*-citrine strategy is unclear. Are the authors using *ctnna* heterozygotes for the cross? What is zGrad targeting in this cross, since the embryos appear to be expressing a citrine fusion protein? Does vhhGFP4 recognize citrine?

*Reviewer \#3:*

In the manuscript \"zGrad is a nanobody-based degron system that inactivates proteins in zebrafish" Yamaguchi, Colak-Champollion and Knaut report the establishment of a nanobody-based tool to degrade GFP-tagged proteins in zebrafish. The authors developed a simple, efficient and spatially- and temporally inducible 1-component system that targets GFP-tagged proteins of interest with different subcellular localizations for degradation by the endogenous ubiquitin-based machinery. Degradation is sufficiently efficient to result in a) loss-of-function phenotypes after global induction of protein degradation, and b) hypomorphic and/or more restricted phenotypes for tissue/time-specific induction of protein degradation.

Compared to the recently published mAID nanobody based 2-component system for zebrafish by the Mansfeld/Norden labs (Daniel et al., 2018), which is most similar to the zGrad tool presented here, zGrad provides a valuable and potentially superior drug-independent 1-component alternative. The main difference of the two systems is the Auxin/TIR1-dependence (mAID) versus independence (zGrad) by using a different degradation-inducing fusion protein to the vhh-GFP4 nanobody: In the case of the published mAID system (Daniel et al., 2018), the nanobody vhh-GFP4 is fused to AID to link via the adaptor protein TIR1 and Auxin to the SCF degradation complex. Degradation in this system was reported to depend on the presence of Auxin. In case of zGrad, the nanobody vhh-GFP4 is fused to Fbxw11b, which binds directly in an Auxin-independent manner to the SCF-complex member Skp1 and thus does not need an additional adaptor to link to the SCF degradation complex. The authors show that the system is inducible by hs- or tissue-specific control of the nanobody fusion construct. Thus, no drugs are needed to induce degradation of GFP-tagged proteins of interest and the newly developed system presented here. Most importantly, the authors present convincing data that zGrad is efficient enough to cause protein-depletion at a level that results in loss-of-function phenotypes.

Overall, zGrad provides a very elegant, simple system to induce protein degradation without the need of drugs or additional adaptor proteins, which also circumvents the problem of potential leakiness of directly AID-tagged target proteins (degradation even in the absence of Auxin). zGrad presents a valuable contribution for functional studies in zebrafish, and will be an important, versatile alternative (and potentially superior, depending on the application) tool that nicely complements other available tools for protein degradation.

The data is of very high quality, and the experiments support the conclusions of the paper.

I have no major concerns.

10.7554/eLife.43125.028

Author response

> Reviewer \#2:
>
> 1\) The paper shows a wide variety of efficiencies in the reduction in levels as well as the timing of degradation for different zGrad target proteins. As proof of principle with sfGFP-ZF1 they co-inject one-cell stage embryos and assay protein levels 9 hours later (Figure 1). What are the results if assayed at 2-3 hpf?

We repeated the mRNA injection experiments and observed sfGFP-ZF1 protein degradation as early as 2.5 hpf. Although the GFP signal in the controls was dim at 2.5 hpf, it was clearly higher than the GFP signal in embryos co-injected with zGrad mRNA (Figure 1---figure supplement 3).

> The authors argue that the system should work within that time frame. For H2A-EGFP the onset of degradation is estimated as 140-200 min while for Ctnna-Citrine it appears to be as early as 65 min. How do the authors account for these differences in onset?

We do not know why Cdh1-GFP and Ctnna-Citrine are degraded faster than H2A-GFP. One difference between these three proteins is their subcellular localization. H2A-GFP is nuclear while Cdh1-GFP is a transmembrane protein with a cytoplasmic tail and Ctnna-Citrine resides fully in the cytoplasm. It is possible that nuclear proteins are less accessible to zGrad-mediated degradation than proteins which are partly of wholly residing in the cytoplasm. Also, the nature of the protein, the complex in which the protein resides and the number of potential ubiquitination sites in the protein will likely contribute to rate of zGrad-mediated degradation.

> 2\) Experiments with H2A-EGFP show widely varied reductions in protein levels in different tissues, which the authors argue reflects different levels of endogenous H2A production. This raises the question of how functional experiments with proteins for which function is unknown can deal with the potential differences in efficiency introduced by variation in the synthesis of new protein? Negative results obtained with zGrad will be extremely hard to interpret. For Figure 2D-E the authors should confirm the hypothesis that the difference in degradation efficiency between somites and lateral line primordia is due to different expression levels of H2A-GFP with in situs for eGFP and mCherry.

We agree that this is a caveat when assessing protein function through protein depletion. However, since the protein of interest will be tagged with a fluorescent protein (FP) it is possible to assess the degree of protein depletion in different tissues and use this information when drawing conclusions. Also, if this is a problem increasing the expression levels of zGrad is an option to increase the degree of FP-tagged protein degradation.

To confirm that the differences in H2A-EGFP degradation efficiencies are due to difference in H2A-EGFP expression levels in somites and the posterior lateral line primodium, we stained embryos for *EGFP* and *mCherry* mRNA at 13 hpf (8-somite stage) and at 33 hpf. Consistent with a previous study \[1\], we find that the *cxcr4b* promoter drives *EGFP* and *mCherry* mRNA expression in the somites at 13 hpf but not at 33 hpf anymore. In contrast, *cxcr4b* drives expression of *EGFP* and *mCherry* mRNA in the primordium at 33 hpf (Figure 2---figure supplement 1). This indicates that the expression of H2A-EGFP protein in the somites at around 30 hpf is due to H2A-EGFP protein perdurance from past *cxcr4b* promoter activity.

> 3\) Variability in the effectiveness of zGrad for Cdh1 to cause cell adhesion defects is explained as being due to variability in zGrad levels. However again this complicates interpretation. Can zGrad levels be monitored and correlated with variability in phenotypic defects? The authors should genotype the embryos to identify those that are cadh+/-;cdh1:cd1-sfgfp;hsp70l:zGrad as the phenotype can only be visualized in these embryos.

We agree and now included an experiment in which we genotyped the embryos for *hsp70l:zGrad* and *cdh1* using cDNA isolated from individual embryos which were phenotypically wild-type or displayed detaching skin cells. As shown in Figure 4, there is a perfect correlation between the heat-shocked embryos with a skin defect and the genotype (*cdh1-/-; cdh1:cdh1-sfGFP; hsp70l:zGrad*, n = 7) and heat-shocked embryos without a skin defect and the genotype (*cdh1-/-; cdh1:cdh1-sfGFP*, n = 1 and *cdh1*-/+ or *cdh1*+/+; *cdh1:cdh1-sfGFP; hsp70l:zGrad* n = 8). For genotyping, we could not use genomic DNA because the *cdh1:cdh1-sfGFP* transgene spans the *cdh1* locus and cannot be distinguished from the endogenous *cdh1* locus by PCR-based genotyping approaches. However, the mRNAs for *cdh1* and *cdh1-sGFP* can be distinguished by PCR based on the different amplicon sizes. We therefore developed a cDNA-based genotyping protocol that we included in our revised manuscript.

> 4\) Interpretation of the results also depends to a great extent on what is co-injected in a given experiment, in terms of amount, and how long it persists in the embryo. This is particularly a potential problem in experiments addressing maternal versus zygotic function.

We agree that the levels and turnover of zGrad will greatly affect the depletion of the FP-tagged target protein. We would like to note, however, that the degree of target protein degradation can easily be monitored by following the fluorescence from the FP-tag. Experiments addressing the function of maternal versus zygotic proteins can be designed in such a way that only the maternal protein or only the zygotic protein is subject to zGrad-mediated degradation. By crossing females homozygous for the gene encoding the FP-tagged target protein to wild-type males homozygous for the untagged/wild-type gene, one can generate embryos in which only the maternal target protein will be degraded by zGrad. Conversely, by crossing females heterozygous for the gene encoding the FP-tagged target protein to males of the same genotype, one can generate embryos in which only the zygotic target protein will be degraded by zGrad. However, as noted by Reviewer 2, in both cases one caveat is that zGrad may not completely deplete the tagged target protein. Therefore, monitoring the fluorescence of the target protein will be essential to assess the degree of protein depletion.

> 5\) The authors should compare the different deGradFP systems used in zebrafish more clearly either in the Introduction or Discussion section to help the reader appreciate the improvements in their system over the previous ones. Since the authors start with results from existing methods and show them in Supplement Figures, it would be helpful if they present their general experimental strategy including the model for the degron system in the first Supplementary Figure.

We agree and now included a discussion of the different degron-based protein depletion systems. We also included schematic cartoons of the different degron-based protein depletion systems (Figure 1A).

> 6\) Clarify the choice of the Slimb system over the C. elegans system, considering that both had similar efficiency of knockdown (19% and 17%).

We tried to adapt the ZIF-1 system to zebrafish by replacing the SOCS box motif in ZIF-1 with a SOCS box from zebrafish. We chose the SOCS box from the zebrafish d-Asb11 protein because it has been shown that d-Asb11 associates with ECS (Elongin BC-Cul2/Cul5-SOCS-box protein) ubiquitin ligase complex to degrade DeltaA in zebrafish \[2\]. However, this ZIF1-d-Asb11 fusion did not degrade GFP-ZF1 more efficiently than ZIF1 ([Author response image 1](#respfig1){ref-type="fig"}). This is why we focused on zGrad for our further experiments

![A zebrafish SOCS box does not increase ZIF-1-mediated degradation of ZF1-tagged GFP.\
(**A**) Schematics of the chimeric protein design carrying ZF1-binding motif from ZIF-1 and SOCS box motif from d-Asb11. (**B**) Embryos injected with sfGFP-ZF1 mRNA or sfGFP-ZF1 and ZIF-1-d-Asb11 mRNA.](elife-43125-resp-fig1){#respfig1}

> 7\) Clarify why the results shown in Figure 2---video 1 and Figure 5---video 1 are so similar -- slight delays in lateral line migration in zGrad expression embryos, which recover over time -- considering the difference in their backgrounds?

Figure 2---video 1 documents the degradation of H2A-GFP upon expression of zGrad from the *cxcr4b* promoter. We used these time lapse videos to assess the degradation efficiency and kinetics of H2A-EGFP in the nuclei of the primordium. The embryos are wild type and express *cxcr4b* from the endogenous locus, and we did not see any migration defects upon zGrad expression.

Figure 5---video 1 documents the consequences of transient Cxcr4b protein loss of function on primordium migration. We used time lapse videos to assess how the depletion of Cxcr4b-EGFP upon zGrad expression from a heat shock promoter in *cxcr4b* mutant embryos affects the migration of the primordium. Note that in *cxcr4b* mutant embryos that carry the *cxcr4b:cxcr4b-EGFP-IRES-Kate2-CaaX* transgene the migration of the primordium is restored \[3\]. We found that transient expression of zGrad efficiently depleted Cxcr4b-EGFP and resulted in primordium stalling. Once Cxcr4b-EGFP levels recovered the primordium resumed its migration. Thus, the two videos document two different aspects -- zGrad-mediated depletion of H2A-EGFP and zGrad mediated Cxcr4b loss of protein function.

> 8\) Figure 3. The ctnna-citrine strategy is unclear. Are the authors using ctnna heterozygotes for the cross? What is zGrad targeting in this cross, since the embryos appear to be expressing a citrine fusion protein? Does vhhGFP4 recognize citrine?

The *Gt(ctnna-citrine)Ct3a* allele is a gene-trap line, in which the coding sequence for the GFP-variant Citrine \[4\] hopped into the *ctnna* locus to generate a Ctnna-Citrine functional fusion protein. The gene-trap coding for *citrine* is inserted in the intron between exon 7 and exon 8 of *ctnna* \[5\]. We found that Ctnna-Citrine protein is degraded by zGrad (Figure 2I-K) indicating that zGrad recognizes Citrine. This is consistent with the observation that deGradFP recognizes and depletes EYFP-tagged Histone in flies \[6\].

We generated embryos in which only maternal Ctnna protein was tagged with Citrine, only zygotic Ctnna protein was tagged with Citrine or both maternal and zygotic Ctnna protein was tagged with Citrine. We injected such embryos with *zGrad* mRNA to assess whether zGrad depletes maternal, zygotic and maternal and zygotic proteins and induces loss of protein function phenotypes. For these genotypes our nomenclature might have been confusing. We indicated fish homozygous for *ctnna:ctnna-citrine* simply as *ctnna:ctnna-citrine* fish instead of *ctnna:ctnna-citrine/ctnna:ctnna-citrine* fish. We are sorry for the confusion this might have caused and now indicate the full genotype of the embryos and adult fish.
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